Xalkori

Xalkori (Crizotinib) is an oral prescription medicine used for treating certain types of non-small cell lung cancer. This targeted therapy works by blocking specific proteins that promote cancer cell growth. Always consult a healthcare professional before use.

Xalkori (Crizotinib) is prescribed to treat adults with non-small cell lung cancer that is anaplastic lymphoma kinase (ALK)-positive or ROS1-positive. It is also used for metastatic non-small cell lung cancer with MET exon 14 skipping alterations. Patients often ask, 'what is Crizotinib used for' in targeted cancer therapy. This medication helps control disease progression in these specific cancer types.

Common effects of Xalkori (Crizotinib) may include nausea, vomiting, diarrhea, or fatigue. Some users report vision changes, such as flashes of light or blurred vision. These effects vary by individual and should be monitored by a healthcare provider.

Store Xalkori (Crizotinib) at room temperature away from moisture and heat. Keep this medication in its original packaging until ready to use. Always handle with care and follow local disposal guidelines for unused or expired medicines. Do not crush, split, or chew capsules.

Xalkori (Crizotinib) may interact with strong CYP3A inhibitors or inducers, altering its effectiveness. Grapefruit products and certain herbal supplements can also affect how this medication works. Always inform your healthcare provider about all medications and supplements you are taking.